company background image
SCS logo

Stem Cells Spin WSE:SCS Stock Report

Last Price

zł0.38

Market Cap

zł14.4m

7D

3.8%

1Y

-0.5%

Updated

23 Jul, 2024

Data

Company Financials

Stem Cells Spin S.A. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Stem Cells Spin
Historical stock prices
Current Share Pricezł0.38
52 Week Highzł0.81
52 Week Lowzł0.30
Beta0.99
11 Month Change-18.88%
3 Month Change-23.79%
1 Year Change-0.53%
33 Year Change-60.62%
5 Year Change-77.50%
Change since IPO-83.20%

Recent News & Updates

Recent updates

Shareholder Returns

SCSPL BiotechsPL Market
7D3.8%1.9%-2.7%
1Y-0.5%-14.0%12.3%

Return vs Industry: SCS exceeded the Polish Biotechs industry which returned -14% over the past year.

Return vs Market: SCS underperformed the Polish Market which returned 12.3% over the past year.

Price Volatility

Is SCS's price volatile compared to industry and market?
SCS volatility
SCS Average Weekly Movement6.9%
Biotechs Industry Average Movement5.3%
Market Average Movement5.0%
10% most volatile stocks in PL Market9.0%
10% least volatile stocks in PL Market3.2%

Stable Share Price: SCS's share price has been volatile over the past 3 months.

Volatility Over Time: SCS's weekly volatility has decreased from 14% to 7% over the past year, but is still higher than 75% of Polish stocks.

About the Company

FoundedEmployeesCEOWebsite
20091Andrzej Kryzarstemcellsspin.com.pl

Stem Cells Spin S.A. operates as a biotechnology company in Poland. It engages in the development, cultivation, and application of stem cells using MIC-1 stem cells for human and veterinary medicine, and dermocosmetics applications. The company offers biodermocosmetics under the Revitacell brand name.

Stem Cells Spin S.A. Fundamentals Summary

How do Stem Cells Spin's earnings and revenue compare to its market cap?
SCS fundamental statistics
Market capzł14.39m
Earnings (TTM)-zł204.45k
Revenue (TTM)zł372.15k

42.0x

P/S Ratio

-76.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SCS income statement (TTM)
Revenuezł372.15k
Cost of Revenuezł44.14k
Gross Profitzł328.02k
Other Expenseszł532.46k
Earnings-zł204.45k

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 14, 2024

Earnings per share (EPS)-0.0049
Gross Margin88.14%
Net Profit Margin-54.94%
Debt/Equity Ratio0.6%

How did SCS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.